<code id='8BDFCC2481'></code><style id='8BDFCC2481'></style>
    • <acronym id='8BDFCC2481'></acronym>
      <center id='8BDFCC2481'><center id='8BDFCC2481'><tfoot id='8BDFCC2481'></tfoot></center><abbr id='8BDFCC2481'><dir id='8BDFCC2481'><tfoot id='8BDFCC2481'></tfoot><noframes id='8BDFCC2481'>

    • <optgroup id='8BDFCC2481'><strike id='8BDFCC2481'><sup id='8BDFCC2481'></sup></strike><code id='8BDFCC2481'></code></optgroup>
        1. <b id='8BDFCC2481'><label id='8BDFCC2481'><select id='8BDFCC2481'><dt id='8BDFCC2481'><span id='8BDFCC2481'></span></dt></select></label></b><u id='8BDFCC2481'></u>
          <i id='8BDFCC2481'><strike id='8BDFCC2481'><tt id='8BDFCC2481'><pre id='8BDFCC2481'></pre></tt></strike></i>

          explore

          explore

          author:focus    Page View:5

          This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

          There is now a drug on the U.S. market, approved this week, called Bkemv. I’m not kidding. I wish I were.

          advertisement

          I’m flying to Chicago today for the ASCO meeting. I’ll be posting cancer-related dispatches all weekend, in case you need something to read on the beach.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Key Senate panel to consider PBM, drug pricing reform package
          Key Senate panel to consider PBM, drug pricing reform package

          Sens.RonWydenandMikeCrapointroducedamentalhealth,PBMreformandsubstanceusepolicypackage.DrewAngerer/G

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          UpToDate has a racism problem: Dr. Stanley Goldfarb

          AdobeTheUniversityofPennsylvania’sDivisionofRenal-ElectrolyteandHypertensionrecentlymadeaquietupdate